Dr. Jonathan Lim is a physician-turned-venturepreneur at City Hill and ARCH Venture who founds, funds and leads mission-driven for-profit and non-profit ventures dedicated to revitalizing people, planet and perspective. Within the City Hill Ventures and ARCH portfolios, Dr. Lim serves as Chairman, CEO and Co-Founder of Erasca; Chairman and Co-Founder of Boundless Bio; and Board Director of Maze Therapeutics. From 2003 to 2018, Dr. Lim was a leader and founding investor of four biotech companies (Halozyme, Eclipse, Ignyta and Bonti) that have collectively delivered seven approved therapeutic products for adult and pediatric indications in oncology, immunology and drug delivery, benefitting thousands of patients globally.
Dr. Lim is a philanthropist and advisor to non-profit organizations through City Hill Foundation and a film producer at City Hill Arts, dedicated to inspiring family entertainment with impact. Earlier in his career, Dr. Lim was a management consultant at McKinsey & Company, an NIH Postdoctoral Fellow at Harvard Medical School and Dana Farber Cancer Institute, and a general surgery resident at New York Hospital-Cornell and Memorial Sloan Kettering Cancer Center. He holds B.S. and M.S. degrees from Stanford University, an M.D. from McGill University, and an M.P.H. from Harvard University.